| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |